Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,759 | -33,937 | -21,413 | -12,778 | -7,021 |
| Depreciation Amortization | 260 | 0 | 413 | 275 | 138 |
| Accounts payable and accrued liabilities | 1,581 | 544 | N/A | N/A | N/A |
| Other Working Capital | 2,182 | 2,061 | -159 | -1,291 | -172 |
| Other Operating Activity | -302 | 7,735 | 4,704 | 3,143 | 1,955 |
| Operating Cash Flow | $-10,038 | $-23,597 | $-16,455 | $-10,651 | $-5,100 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | -297 | 0 | N/A | N/A | N/A |
| Other Investing Activity | -19 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-316 | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 89,988 | 97,099 | 27,988 | 28,017 | 18,906 |
| Other Financing Activity | 0 | -395 | 0 | 0 | 0 |
| Financing Cash Flow | $89,988 | $96,704 | $27,988 | $28,017 | $18,906 |
| Exchange Rate Effect | 313 | 284 | N/A | N/A | N/A |
| Beginning Cash Position | 80,094 | 6,703 | 6,702 | 6,702 | 6,702 |
| End Cash Position | 160,041 | 80,094 | 18,235 | 24,068 | 20,508 |
| Net Cash Flow | $79,947 | $73,391 | $11,533 | $17,366 | $13,806 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,038 | -23,597 | -16,455 | -10,651 | -5,100 |
| Free Cash Flow | -10,038 | -23,597 | -16,455 | -10,651 | -5,100 |